DADC
ONCS

D.A. Davidson & Co’s OncoSec Medical Incorporated ONCS Stock Holding History

D.A. Davidson & Co’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-727
Closed -$12K – 1365
2022
Q2 		$12K Sell
727
-1,659
-70% -$31.8K ﹤0.01% 1269
2022
Q1 		$60K Sell
2,386
-228
-9% -$4.81K ﹤0.01% 1266
2021
Q4 		$55K Sell
2,614
-2,318
-47% -$78.4K ﹤0.01% 1249
2021
Q3 		$231K Sell
4,932
-336
-6% -$17K ﹤0.01% 1104
2021
Q2 		$326K Sell
5,268
-50
-0.9% -$4.54K ﹤0.01% 960
2021
Q1 		$558K Sell
5,318
-46
-0.9% -$6.29K 0.01% 769
2020
Q4 		$761K Sell
5,364
-45
-0.8% -$4.8K 0.01% 575
2020
Q3 		$402K Buy
5,409
+23
+0.4% +$1.79K 0.01% 683
2020
Q2 		$243K Buy
5,386
+2,306
+75% +$98.1K ﹤0.01% 806
2020
Q1 		$86K Hold
3,080
– – ﹤0.01% 948
2019
Q4 		$123K Buy
3,080
+1,989
+182% +$89.9K ﹤0.01% 978
2019
Q3 		$47K Buy
+1,091
New +$51.2K ﹤0.01% 989
2019
Q2 		– Sell
-261
Closed -$32K – 1194
2019
Q1 		$32K Hold
261
– – ﹤0.01% 1129
2018
Q4 		$37K Buy
261
+45
+21% +$11.3K ﹤0.01% 1081
2018
Q3 		$67K Buy
216
+11
+5% +$3.38K ﹤0.01% 1147
2018
Q2 		$62K Buy
205
+7
+4% +$2.45K ﹤0.01% 1104
2018
Q1 		$82K Buy
+198
New +$81.2K ﹤0.01% 1078

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.A. Davidson & Co's ONCS Position: Q3 2022 in Review

D.A. Davidson & Co sold out of OncoSec Medical Incorporated (ONCS) in Q3 2022, closing a stake of 727 shares — an estimated $12K sold.

D.A. Davidson & Co first reported a position in ONCS in Q1 2018 and held it in 17 quarters. The position peaked at $761K in Q4 2020. 23 funds tracked by Wall St. Rank hold ONCS as of Q3 2022.

  • D.A. Davidson & Co reported no remaining OncoSec Medical Incorporated position as of Q3 2022 after selling out during the quarter.
  • D.A. Davidson & Co sold 727 OncoSec Medical Incorporated shares in Q3 2022, an estimated $12K.
  • D.A. Davidson & Co first reported a position in OncoSec Medical Incorporated in Q1 2018 and held it in 17 quarters.
  • D.A. Davidson & Co's OncoSec Medical Incorporated position peaked at $761K in Q4 2020.
  • 23 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2022.

Based on D.A. Davidson & Co's 13F filing for Q3 2022, filed 7 Nov 2022.